Salvage Surgery Following Remarkable Tumor Shrinkage With Enfortumab Vedotin in Advanced Urothelial Carcinoma
EV therapy suggests that it is a promising avenue for further exploration, potentially redefining the therapeutic landscape of historically challenging cases.
Authors
- Tatsu Tanabe (ORCID: https://orcid.org/0009-0003-6167-9774)
- Keita Minami (ORCID: https://orcid.org/0000-0001-7339-0079)
- Hiroshi Tanaka (ORCID: https://orcid.org/0000-0002-1812-332X)
- Hajime Sasaki (ORCID: https://orcid.org/0000-0001-7639-0912)
- Rei Narimatsu (ORCID: https://orcid.org/0009-0006-3211-5461)
Institutions
- Sapporo City General Hospital (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1002/iju5.70019
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01